No. 10 Medical Innovation for 2018: Scalp Cooling for Reducing Chemotherapy Hair Loss (Video)

FDA approved technology in 2017

The practice of “scalp cooling,” which reduces the temperature of the scalp a few degrees immediately before, during and after chemotherapy, has been shown to be highly effective in preserving hair in women receiving chemotherapy for early-stage breast cancer. The scalp cooling system was approved by the FDA in May 2017.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

In this video, learn more about why scalp cooling for reducing chemotherapy hair loss is one of Cleveland Clinic’s Top 10 Medical Innovations for 2018.